Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference10 articles.
1. Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet
https://doi.org/10.1016/S0140-6736(19)30427-1
(2019).
2. Nabel, E. G. & Braunwald, E. A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54–63 (2012).
3. Ministry of Science and Technology of the People’s Republic of China. 2017 statistics on investment in research and development [Chinese]. Ministry of Science and Technology of the People’s Republic of China
http://www.most.gov.cn/mostinfo/xinxifenlei/kjtjyfzbg/kjtjbg/kjtj2018/201902/P020190225562371257913.pdf
(2017).
4. Lansky, A. et al. Targeted therapy with a localised abluminal groove, low-dose sirolimus-eluting, biodegradable polymer coronary stent (TARGET All Comers): a multicentre, open-label, randomised non-inferiority trial. Lancet 392, 1117–1126 (2018).
5. Han, Y. et al. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial. JAMA 313, 1336–1346 (2015).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献